David Russler-Germain

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

David Russler-Germain

Aug 23, 2024, 14:13 | Insight

Oncology Brothers: Discussions around the algorithm for DLBCL

Oncology Brothers shared on X: "This is the algorithm we have used during our discussion…

Jul 15, 2024, 13:06 | Opinion

Neha Mehta-Shah: Two weeks of jam packed teaching at Washington University School of Medicine

Neha Mehta-Shah, Assistant Professor at Washington University in St. Louis, shared a post by WashU…

Jun 19, 2024, 13:46 | Insight

David Russler-Germain: Swapping in BrECADD for PET adapted approaches

David Russler-Germain, Oncology Instructor at Siteman Cancer Center, shared a post by Graham Collins, Associate…

Oct 17, 2023, 01:19 | Drugs

Edward Cliff: POLARIX trial of antibody-drug conjugate polatuzumab vedotin in diffuse large B-cell lymphoma.

Edward Cliff, Postdoctoral Research Fellow at Harvard Medical School, shared on LinkedIn: “Just out in…

All: 4 Posts: 1 - 100

'

Hilights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023